News | October 31, 2011

Lantheus Awarded Supplier Agreement with Premier for Radiopharmaceutical Products

October 31, 2011 –Lantheus Medical announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.

Effective Jan. 1, 2012 through Dec. 31, 2014, the new radiopharmaceutical products agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Cardiolite (kit for the preparation of Technetium Tc99m Sestamibi for injection), Gallium 67 (Gallium Citrate Ga67 injections), Neurolite (kit for the preparation of Technetium Tc99m Bicisate for Injection), TechneLite (Technetium Tc99m generator), 201 Thallium (Thallous Chloride Tl201 Injection) and Xenon 133 (Xenon Xe 133 gas).

Lantheus’ radiopharmaceutical products will be offered through a specially negotiated contract to more than 2,500 hospitals nationwide and 76,000-plus healthcare sites. The contract was awarded after a competitive bidding process that examined multiple factors, including pricing and clinical experience with the diagnostic imaging agents, as well as Lantheus’ support of the products.

Please visit www.lantheus.com


Additional Content

News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Home September 02, 2026
Home
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Home May 07, 2026
Home
News | Radiopharmaceuticals and Tracers

March 27, 2025 — GE HealthCare is announcing the U.S. launch of Flyrcado (flurpiridaz F 18) injection at the 2025 ...

Home March 25, 2025
Home
News | Radiopharmaceuticals and Tracers

April 13, 2023 — A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin ...

Home April 13, 2023
Home
News | Radiopharmaceuticals and Tracers

Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical ...

Home November 05, 2022
Home
Subscribe Now